Skip to main content
    S

    Sutro Biopharma (STRO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $9.32
    -0.50 (-5.09%)

    Market Cap: $163.03M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Sutro Biopharma (STRO) Earnings: Report Dates and Results

    Updated Nov 12, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Sutro Biopharma (STRO) is expected to report earnings on Mar 22, 2027. In the quarter ended Sep 30, 2026, Sutro Biopharma reported EPS of -$1.90, below the -$1.88 estimate. It beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    52%(16/31)
    Avg Surprise
    +1.79%

    Upcoming Estimates

    Reports Mar 22, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$1.72
    Range-$2.70 - -$0.95
    16 analysts
    Revenue Consensus
    $11.62M
    Range$2.45M - $21.96M
    14 analysts

    Next Report

    STRO has an expected report date of Mar 22, 2027.

    Earnings History

    Of the 31 quarters below that had an estimate, STRO beat 16 and missed 15. Revenue for the quarter ended Sep 30, 2026 was $9.10M, down 6.1% from $9.69M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$1.90-$1.88-$2.38 - -$1.45-1.06%MissN/A31 up, 0 downNov 12, 2026$9.10M
    Jun 30, 2026-$2.33-$2.04N/A-14.22%MissN/A30 up, 0 downAug 12, 2026$9.84M
    Mar 31, 2026-$2.94-$3.21-$3.65 - -$2.78+8.41%BeatN/A20 up, 0 downMay 14, 2026$14.52M
    Dec 31, 2025-$5.45-$0.43-$0.46 - -$0.43N/AN/AN/A21 up, 0 downMar 23, 2026$11.65M
    Sep 30, 2025-$5.57-$3.55N/A-56.90%MissN/A11 up, 0 downNov 6, 2025$9.69M
    Jun 30, 2025-$0.14-$0.39N/A+64.10%BeatN/A10 up, 0 downAug 7, 2025$63.74M
    Mar 31, 2025-$8.02-$9.20N/A+12.83%BeatN/AN/A0 up, 0 downMay 8, 2025$17.40M
    Dec 31, 2024-$0.63-$0.96-$1.13 - -$0.78+33.70%Beat-221.8%20 up, 2 downMar 13, 2025$14.81M
    Sep 30, 2024-$4.98-$7.35-$8.90 - -$5.40+32.24%BeatN/A110 up, 0 downNov 13, 2024$8.52M
    Jun 30, 2024-$5.61-$9.00-$10.40 - -$0.90+37.67%BeatN/A100 up, 0 downAug 13, 2024$25.71M
    Mar 31, 2024-$8.90-$9.95-$10.90 - -$7.20+10.55%BeatN/A100 up, 0 downMay 13, 2024$13.01M
    Dec 31, 2023$0.52-$0.82-$0.94 - -$0.71+163.41%BeatN/A90 up, 0 downMar 25, 2024$113.72M
    Sep 30, 2023-$8.10-$7.15-$8.40 - -$5.60-13.29%MissN/A100 up, 0 downNov 13, 2023$16.92M
    Jun 30, 2023-$7.69-$6.87-$8.40 - -$6.30-11.94%MissN/A80 up, 0 downAug 10, 2023$10.41M
    Mar 31, 2023-$0.85-$0.81-$0.99 - -$0.68-4.94%MissN/A70 up, 0 downMay 15, 2023$12.67M
    Dec 31, 2022-$8.18-$6.32-$8.40 - -$3.30-29.43%MissN/A80 up, 1 downMar 30, 2023$8.63M
    Sep 30, 2022-$3.70$0.12N/AN/AN/AN/A60 up, 0 downNov 8, 2022$25.15M
    Jun 30, 2022-$5.50-$7.70-$8.80 - $10.80+28.57%BeatN/A71 up, 0 downAug 8, 2022$28.10M
    Mar 31, 2022-$8.40-$7.37-$9.50 - -$5.40-13.98%MissN/A80 up, 0 downMay 9, 2022$5.90M
    Dec 31, 2021-$0.83-$0.69-$0.94 - -$0.42-20.29%MissN/A8N/AFeb 28, 2022$10.65M
    Sep 30, 2021-$6.70-$4.80N/A-39.58%MissN/A80 up, 0 downNov 10, 2021$8.52M
    Jun 30, 2021-$1.30-$4.00-$5.60 - -$2.40+67.50%BeatN/A8N/AAug 9, 2021$28.05M
    Mar 31, 2021-$4.28-$6.00-$7.30 - -$4.80+28.67%BeatN/A7N/AMay 7, 2021$14.66M
    Dec 31, 2020-$1.48-$0.57-$0.77 - -$0.33-159.65%MissN/A8N/AMar 18, 2021$8.28M
    Sep 30, 2020-$3.34-$5.00-$7.00 - -$2.60+33.20%BeatN/A7N/ANov 5, 2020$17.82M
    Jun 30, 2020-$5.97-$5.74-$8.50 - -$4.70-4.01%MissN/A8N/AAug 6, 2020$9.47M
    Mar 31, 2020-$8.40-$5.68-$9.40 - -$4.90-47.89%MissN/A7N/AMay 11, 2020$7.15M
    Dec 31, 2019-$0.64-$0.69-$0.83 - -$0.56+7.25%BeatN/A8N/AMar 16, 2020$11.30M
    Sep 30, 2019-$5.60-$6.17-$7.50 - -$4.30+9.24%BeatN/A7N/ANov 8, 2019$12.28M
    Jun 30, 2019-$6.00-$6.01-$8.00 - -$5.70+0.17%BeatN/A4N/AAug 14, 2019$10.53M
    Mar 31, 2019-$6.20-$6.10-$7.00 - -$5.50-1.64%MissN/A4N/AApr 1, 2019$8.63M
    Dec 31, 2018-$0.26-$0.63-$0.73 - -$0.53+58.73%BeatN/A4N/ADec 31, 2018$19.09M
    Sep 30, 2018-$4.34$19.70N/A-122.03%MissN/A4N/ANov 14, 2018$7.84M
    Jun 30, 2018-$1.37N/AN/AN/AN/AN/AN/AN/ASep 26, 2018$5.70M
    Last 34 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$19.18, after -$20.12 the year before. It was -$5.97 for the year ended Dec 31, 2018, the oldest of the 8 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$19.18N/A
    Dec 31, 2024-$20.12N/A
    Dec 31, 2023-$16.12N/A
    Dec 31, 2022-$25.78N/A
    Dec 31, 2021-$13.11N/A
    Dec 31, 2020-$19.19N/A
    Dec 31, 2019-$18.44N/A
    Dec 31, 2018-$5.97N/A

    Frequently Asked Questions About STRO

    When is Sutro Biopharma's next earnings date?

    Sutro Biopharma's next earnings report is expected for Mar 22, 2027.

    Did STRO beat earnings estimates last quarter?

    No. Sutro Biopharma reported EPS of -$1.90 for the quarter ended Sep 30, 2026, below the -$1.88 estimate by 1.06%.

    What EPS do analysts expect from STRO next quarter?

    The consensus EPS estimate for Sutro Biopharma for the quarter ending Dec 31, 2026 is -$1.72 from 16 analysts, with estimates from -$2.70 to -$0.95.

    How often does STRO beat earnings estimates?

    Sutro Biopharma beat the EPS estimate in 5 of the 8 most recent quarters that had an estimate, with an average surprise of +9.89%.